MNK Controls mTORC1:Substrate Association through Regulation of TELO2 Binding with mTORC1.
about
Oncogenic MNK signalling regulates the metastasis suppressor NDRG1Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs.Recombinant Poliovirus for Cancer Immunotherapy.A whole-animal platform to advance a clinical kinase inhibitor into new disease space.Regulation of HIF-1α during Hypoxia by DAP5-Induced Translation of PHD2.eIF4E Phosphorylation in Prostate Cancer.MNK inversely regulates TELO2 vs. DEPTOR to control mTORC1 signaling.Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer CellsActive-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axisMetformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling
P2860
Q38763490-4DEE9E8F-442D-40CD-8F36-83DD62FCF9FDQ48319918-8F52CA83-4CE0-49FC-971D-DC8CD56B73BEQ48508304-8DF4E851-F02A-4848-9CB5-00543865531BQ49884409-7612EB92-9E08-4294-B2FE-41B38CEF5500Q52358485-1C2C4083-DE11-43CB-89A1-71F6A218FD46Q53687330-99755D25-BB9A-4CFB-943A-0AA51A2FEBACQ53817111-3E4722BB-3369-40E2-AB50-0980735AAB70Q57753028-D592E2C1-8CB6-4F1C-A1A5-8A7CED9352CAQ58711851-E284C632-57A1-4276-83EC-F89DA29B99FFQ59137532-EF1A7A50-A4A2-4344-B392-6FF26329D526
P2860
MNK Controls mTORC1:Substrate Association through Regulation of TELO2 Binding with mTORC1.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
MNK Controls mTORC1:Substrate ...... of TELO2 Binding with mTORC1.
@en
type
label
MNK Controls mTORC1:Substrate ...... of TELO2 Binding with mTORC1.
@en
prefLabel
MNK Controls mTORC1:Substrate ...... of TELO2 Binding with mTORC1.
@en
P2860
P1433
P1476
MNK Controls mTORC1:Substrate Association through Regulation of TELO2 Binding with mTORC1
@en
P2093
Matthias Gromeier
P2860
P304
P356
10.1016/J.CELREP.2017.01.023
P577
2017-02-01T00:00:00Z